Systemic FGF-23 levels rapidly increase as renal function declines, and this occurs before an increase in other markers, such as parathyroid hormone, vitamin D or even phosphorus, likely as a compensatory mechanism to prevent hyperphosphatemia after ARF [28,29]. This evidence concerns the gene FGF23 and hyperphosphatemia.